RECRUITING
I'm interested ...!!
Mindfulness in Endometrial and Cervical Cancer
Patients with endometrial cancer who will be undergoing surgery or patients with cervical cancer who will be treated with chemoradiation will be randomized to utilize the Headspace smartphone application or not prior to their anticipated treatment.
Conditions:
🦠 Gynecologic Cancer 🦠 Endometrial Cancer 🦠 Cervical Cancer 🦠 Quality of Life 🦠 Opioid Use
🗓️ Study Start (Actual) 25 July 2020
🗓️ Primary Completion (Estimated) 30 July 2024
✅ Study Completion (Estimated) 30 July 2024
👥 Enrollment (Estimated) 120
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Saint Louis, Missouri, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * New diagnosis of either 1) endometrial cancer undergoing surgery or 2) cervical cancer undergoing chemo-sensitizing radiation
    • * Access to a smartphone

    Exclusion Criteria:

    • * Non-English speaking
    • * No access to smartphone
    • * Current use of Headspace application
Ages Eligible for Study: 18 Years to 90 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 26 July 2020
  • First Submitted that Met QC Criteria 10 August 2020
  • First Posted 13 August 2020

Study Record Updates

  • Last Update Submitted that Met QC Criteria 8 September 2023
  • Last Update Posted 11 September 2023
  • Last Verified September 2023
I'm interested ...!!